Puracyp, tools for drug discovery
Puracyp offers screening services to assess the activation of nuclear receptors. Our panel screens include AhR, CAR and PXR from human, rat, dog, mouse and monkey. Our contract services provide cost efficient study designs in mammalian cell lines, for functional activation of all three nuclear receptors. Because results are easily interpreted, numerous companies use Puracyp systems to predict adverse effects and drug-drug interactions caused by environmental and therapeutic agents.